Therapeutic Targeting of Acute Myeloid Leukemia by Gemtuzumab OzogamicinMichele Gottardi, Giovanni Martinelli, Gerardo Musuraca et al.|Cancers|2021Cited by 19
Gemtuzumab ozogamicin in acute myeloid leukemia: past, present and futureMichele Gottardi, Claudio Cerchione, Giorgia Simonetti et al.|Minerva Medica|2020Cited by 18
CPX-351 daunorubicin-cytarabine liposome: a novel formulation to treat patients with newly diagnosed secondary acute myeloid leukemiaAlessandro Cafaro, Claudio Cerchione, Maria Benedetta Giannini et al.|Minerva Medica|2020Cited by 13
Pharmacological Inhibition of WIP1 Sensitizes Acute Myeloid Leukemia Cells to the MDM2 Inhibitor Nutlin-3aMaria Chiara Fontana, Giorgia Simonetti, Jacopo Nanni et al.|Biomedicines|2021Cited by 11
Tagraxofusp and anti-CD123 in blastic plasmacytoid dendritic cell neoplasm: a new hopeDelia Cangini, Claudio Cerchione, Paolo Silimbani et al.|Minerva Medica|2020Cited by 10